Contact

All Stories

  1. What do we know about health technology assessment (HTA) in Africa?

    Article • F1000Research, May 2020, Faculty of 1000, Ltd.

    Dr Sam Hollingworth

  2. Bortezomib use and outcomes for the treatment of multiple myeloma

    Article • Internal Medicine Journal, May 2020, Wiley

    Dr Sam Hollingworth

  3. What do we need to know? Data sources to support evidence-based decisions using health technology assessment in Ghana

    Article • Health Research Policy and Systems, April 2020, Springer Science + Business Media

    Dr Sam Hollingworth

  4. Antifungal agents for invasive candidiasis in non-neutropenic critically ill adults: What do the guidelines recommend?

    Article • International Journal of Infectious Diseases, December 2019, Elsevier

    Dr Sam Hollingworth, Associate Professor Treasure Madeleine McGuire

  5. Implementing health technology assessment in Ghana to support universal health coverage: building relationships that focus on people, policy, and process

    Article • International Journal of Technology Assessment in Health Care, November 2019, Cambridge University Press

    Dr Sam Hollingworth

  6. Strategies to counter antipsychotic-associated weight gain in patients with schizophrenia

    Article • Expert Opinion on Drug Safety, October 2019, Taylor & Francis

    Professor Steve R Kisely, Wade Marteene, Dr Sam Hollingworth

  7. How prepared are pharmacists to provide over-the-counter naloxone? The role of previous education and new training opportunities

    Article • Research in Social and Administrative Pharmacy, August 2019, Elsevier

    Dr Sam Hollingworth

  8. Longitudinal impact of the Women’s Health Initiative study on hormone therapy use in Australia

    Article • Climacteric, April 2019, Taylor & Francis

    Associate Professor Treasure Madeleine McGuire, Rifani Natari, Dr Sam Hollingworth

  9. Does consumer medicines interest reflect medicines use? An observational study comparing medicines call center queries with medicines use

    Article • Research in Social and Administrative Pharmacy, April 2019, Elsevier

    Dr Sam Hollingworth, Associate Professor Treasure Madeleine McGuire

  10. Medicine use during acute and chronic postinjury periods in whiplash-injured individuals

    Article • Pain, April 2019, Wolters Kluwer Health

    Dr Sam Hollingworth

  11. Cost-effectiveness Analysis of Routine Screening Using Massively Parallel Sequencing for Maturity-Onset Diabetes of the Young in a Pediatric Diabetes Cohort: Reduced Health System Costs and Improved Patient Quality of Life

    Article • Diabetes Care, December 2018, American Diabetes Association

    Dr Sam Hollingworth

  12. Forecasting the amount and cost of medicine to treat type 2 diabetes mellitus in Nepal using knowledge on medicine usage from a developed country

    Article • Journal of Pharmaceutical Health Services Research, August 2018, Wiley

    Dr Sam Hollingworth

  13. Prescription Opioid Fatalities: Examining Why the Healer Could be the Culprit

    Article • Drug Safety, May 2018, Springer Science + Business Media

    Dr Adeleke David Adewumi, Dr Sam Hollingworth

  14. Survival outcomes in patients with non-small-cell lung cancer treated with erlotinib

    Article • Anti-Cancer Drugs, May 2018, Wolters Kluwer Health

    Dr Sam Hollingworth

  15. Correction to: Clozapine-related neutropenia, myocarditis and cardiomyopathy adverse event reports in Australia 1993–2014

    Article • Psychopharmacology, April 2018, Springer Science + Business Media

    Dr Sam Hollingworth

  16. Use of complementary and alternative medicines in people with depression and central obesity: Findings from a Tai Chi and Qigong study

    Article • Journal of Traditional Chinese Medical Sciences, April 2018, Elsevier

    Dr Sam Hollingworth

  17. Clozapine-related neutropenia, myocarditis and cardiomyopathy adverse event reports in Australia 1993–2014

    Article • Psychopharmacology, March 2018, Springer Science + Business Media

    Dr Sam Hollingworth

  18. Cost saving with a GP-led integrated health service delivery model for complex chronic disease: an optimal Beacon practice

    Article • International Journal of Integrated Care, March 2018, Ubiquity Press, Ltd.

    Dr Sam Hollingworth

  19. Prescribed Dose of Opioids and Overdose: A Systematic Review and Meta-Analysis of Unintentional Prescription Opioid Overdose

    Article • CNS Drugs, March 2018, Springer Science + Business Media

    Dr Adeleke David Adewumi, Dr Sam Hollingworth

  20. More needs to be spent on hepatitis C treatment, not less

    Article • Internal Medicine Journal, March 2018, Wiley

    Dr Sam Hollingworth

  21. Patterns in use and costs of subsidising 5-aminosalicyclic acid compounds and biologic agents in the treatment of inflammatory bowel disease in Australia

    Article • Digestive and Liver Disease, March 2018, Elsevier

    Dr Sam Hollingworth

  22. Treatment of clozapine-associated obesity and diabetes with exenatide in adults with schizophrenia: A randomized controlled trial (CODEX)

    Article • Diabetes Obesity and Metabolism, December 2017, Wiley

    Dr Sam Hollingworth

  23. Impact of a general practitioner-led integrated model of care on the cost of potentially preventable diabetes-related hospitalisations

    Article • Primary Care Diabetes, August 2017, Elsevier

    Dr Sam Hollingworth

  24. The bidirectional relationship between vasomotor symptoms and depression across the menopausal transition

    Article • Menopause The Journal of The North American Menopause Society, July 2017, Wolters Kluwer Health

    Associate Professor Treasure Madeleine McGuire, Rifani Natari, Dr Sam Hollingworth

  25. Opioid analgesic use in Australia and The Netherlands: a cross-country comparison

    Article • International Journal of Clinical Pharmacy, June 2017, Springer Science + Business Media

    Dr Sam Hollingworth

  26. Using pharmacy management systems for research: survival outcomes for lenalidomide in multiple myeloma in the clinical setting

    Article • International Journal of Clinical Pharmacy, June 2017, Springer Science + Business Media

    Dr Sam Hollingworth

  27. International trends in clozapine use: a study in 17 countries

    Article • Acta Psychiatrica Scandinavica, May 2017, Wiley

    Dr Prasad S Nishtala, Dr Jorge E Machado-Alba, Dr Sam Hollingworth

  28. Prescribing patterns of analgesics and other medicines by dental practitioners in Australia from 2001 to 2012

    Article • Community Dentistry And Oral Epidemiology, March 2017, Wiley

    Dr Pauline J Ford, Dr Sam Hollingworth

  29. The impact of clozapine on hospital use: a systematic review and meta-analysis

    Article • Acta Psychiatrica Scandinavica, February 2017, Wiley

    Dr Sam Hollingworth

  30. Triptan use in Australia 1997-2015: A pharmacoepidemiological study

    Article • Acta Neurologica Scandinavica, January 2017, Wiley

    Dr Sam Hollingworth

  31. Forecasting the quantity and cost of medicines to treat non-communicable diseases in low- and middle-income countries: Applying knowledge on medicine use from developed countries

    Article • Research in Social and Administrative Pharmacy, January 2017, Elsevier

    Dr Sam Hollingworth

  32. Use of Healthcare Services by Patients with Non-Communicable Diseases in Nepal: A Qualitative Study with Healthcare Providers

    Article • JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH, January 2017, JCDR Research and Publications

    Dr Sam Hollingworth

  33. Under-reporting of socio-economic status in randomized control trials of biologic disease-modifying anti-rheumatic drugs in rheumatoid arthritis

    Article • Rheumatology, December 2016, Oxford University Press (OUP)

    Dr Sam Hollingworth

  34. Prescribing patterns of dental practitioners in Australia from 2001 to 2012. Antimicrobials

    Article • Australian Dental Journal, December 2016, Wiley

    Dr Pauline J Ford, Dr Sam Hollingworth

  35. Ezetimibe: Use, costs, and adverse events in Australia

    Article • Cardiovascular Therapeutics, December 2016, Wiley

    Dr Sam Hollingworth

  36. Off-label use of tumour necrosis factor-alpha inhibitors and anakinra at an Australian tertiary hospital

    Article • Internal Medicine Journal, December 2016, Wiley

    Dr Sam Hollingworth

  37. Case conference primary-secondary care planning at end of life can reduce the cost of hospitalisations

    Article • BMC Palliative Care, September 2016, Springer Science + Business Media

    Dr Sam Hollingworth

  38. Knowledge and attitudes of final year pharmacy students toward opioid substitution therapy

    Article • Journal of Pharmacy Practice and Research, July 2016, Wiley

    Dr Centaine L Snoswell, Dr Sam Hollingworth

  39. Effectiveness of bevacizumab and cetuximab in metastatic colorectal cancer across selected public hospitals in Queensland

    Article • Asia-Pacific Journal of Clinical Oncology, July 2016, Wiley

    Dr Sam Hollingworth

  40. Associations of Guideline Recommended Medications for Acute Coronary Syndromes With Fall-Related Hospitalizations and Cardiovascular Events in Older Women With Ischemic Heart Disease

    Article • The Journals of Gerontology Series A, July 2016, Oxford University Press (OUP)

    Dr Sam Hollingworth

  41. Pharmacy workforce to prevent and manage non-communicable diseases in developing nations: The case of Nepal

    Article • Research in Social and Administrative Pharmacy, July 2016, Elsevier

    Dr Sam Hollingworth

  42. A Review of Medication Use as an Indicator of Human Health Impact in Environmentally Stressed Areas

    Article • Annals of Global Health, June 2016, Ubiquity Press, Ltd.

    Dr Sam Hollingworth

  43. ‘Repeat’ prescriptions and antibiotic resistance: findings from Australian community pharmacy

    Article • International Journal of Pharmacy Practice, June 2016, Wiley

    Dr Sam Hollingworth

  44. Understanding quality use of medicines in refugee communities in Australian primary care: a qualitative study

    Article • British Journal of General Practice, May 2016, Royal College of General Practitioners

    Dr Sam Hollingworth

  45. Glucagon-like peptide-1 agonists combating clozapine-associated obesity and diabetes

    Article • Journal of Psychopharmacology, January 2016, SAGE Publications

    Dr Sam Hollingworth

  46. Consumer knowledge and perceptions about antibiotics and upper respiratory tract infections in a community pharmacy

    Article • International Journal of Clinical Pharmacy, September 2015, Springer Science + Business Media

    Dr Sam Hollingworth

  47. Dopamine Agonists: Time Pattern of Adverse Effects Reporting in Australia

    Article • Drugs - Real World Outcomes, July 2015, Springer Science + Business Media

    Associate Professor Treasure Madeleine McGuire, Dr Sam Hollingworth

  48. Shift in disease burden from communicable to non-communicable diseases: aiming to achieve Universal Health Coverage in Nepal

    Article • Perspectives in Public Health, July 2015, SAGE Publications

    Dr Sam Hollingworth

  49. Clozapine in the community: Improved access or risky free-for-all?

    Article • Australian & New Zealand Journal of Psychiatry, June 2015, SAGE Publications

    Dr Sam Hollingworth

  50. Increasing Clozapine Dispensing Trends in Queensland, Australia 2004–2013

    Article • Pharmacopsychiatry, June 2015, Thieme Publishing Group

    Dr Sam Hollingworth

  51. Treatment of clozapine-associated obesity and diabetes with exenatide (CODEX) in adults with schizophrenia: study protocol for a pilot randomised controlled trial

    Article • BJPsych Open, June 2015, Royal College of Psychiatrists

    Dr Sam Hollingworth

  52. Opioid analgesic prescribing in Australia: a focus on gender and age

    Article • Pharmacoepidemiology and Drug Safety, April 2015, Wiley

    Wayne Hall, Dr Sam Hollingworth

  53. Multiple sclerosis disease modifying medicine utilisation in Australia

    Article • Journal of Clinical Neuroscience, December 2014, Elsevier

    Dr Sam Hollingworth

  54. Clozapine-induced myocarditis: Separating the wheat from the chaff

    Article • Australian & New Zealand Journal of Psychiatry, October 2014, SAGE Publications

    Dr Sam Hollingworth

  55. Effects of decentralisation and health system reform on health workforce and quality-of-care in Indonesia, 1993-2007

    Article • The International Journal of Health Planning and Management, May 2014, Wiley

    Dr Sam Hollingworth

  56. Quality of physical resources of health facilities in Indonesia: a panel study 1993-2007

    Article • International Journal for Quality in Health Care, August 2013, Oxford University Press (OUP)

    Dr Sam Hollingworth

  57. National trends in the community prescribing of second-generation antipsychotic medications in Australian children and youth: the incomplete story

    Article • Australasian Psychiatry, July 2013, SAGE Publications

    Dr Sam Hollingworth

  58. Prescribing databases can be used to monitor trends in opioid analgesic prescribing in Australia

    Article • Australian and New Zealand Journal of Public Health, April 2013, Wiley

    Dr Sam Hollingworth

  59. Pharmacoepidemiology and the Australian regional prevalence of multiple sclerosis

    Article • Multiple Sclerosis Journal, March 2013, SAGE Publications

    Dr Sam Hollingworth

  60. A new model of integrated primary-secondary care for complex diabetes in the community: study protocol for a randomised controlled trial

    Article • Trials, January 2013, Springer Science + Business Media

    Dr Sam Hollingworth

  61. The prescribing of antiepileptic drugs for pregnant Australian women

    Article • Australian and New Zealand Journal of Obstetrics and Gynaecology, September 2011, Wiley

    Dr Sam Hollingworth

  62. Psychiatric Drug Prescribing in Elderly Australians: Time for Action

    Article • Australian & New Zealand Journal of Psychiatry, September 2011, SAGE Publications

    Dr Sam Hollingworth

  63. Australian National Trends in Stimulant Dispensing: 2002–2009

    Article • Australian & New Zealand Journal of Psychiatry, April 2011, SAGE Publications

    Dr Sam Hollingworth

  64. Utilization of anti-Parkinson drugs in Australia: 1995-2009

    Article • Pharmacoepidemiology and Drug Safety, February 2011, Wiley

    Dr Sam Hollingworth

  65. Prescribing trends in cognition enhancing drugs in Australia

    Article • International Psychogeriatrics, July 2010, Cambridge University Press

    Dr Sam Hollingworth

  66. Marked increase in proton pump inhibitors use in Australia

    Article • Pharmacoepidemiology and Drug Safety, July 2010, Wiley

    Dr Sam Hollingworth

  67. Patterns of Antipsychotic Medication Use in Australia 2002–2007

    Article • Australian & New Zealand Journal of Psychiatry, April 2010, SAGE Publications

    Dr Sam Hollingworth

  68. Secondary Prevention of Osteoporosis in Australia

    Article • Drugs & Aging, March 2010, Springer Science + Business Media

    Dr Sam Hollingworth

  69. Changing patterns of antiepileptic drug use in pregnant Australian women

    Article • Acta Neurologica Scandinavica, February 2010, Wiley

    Dr Sam Hollingworth

  70. Anxiolytic, hypnotic and sedative medication use in Australia

    Article • Pharmacoepidemiology and Drug Safety, January 2010, Wiley

    Dr Sam Hollingworth

  71. Antiepileptic drugs in Australia: 2002–2007

    Article • Pharmacoepidemiology and Drug Safety, January 2010, Wiley

    Dr Sam Hollingworth

  72. In Australia are people born in other countries at higher risk of road trauma than locally born people?

    Article • Accident Analysis & Prevention, May 2004, Elsevier

    Dr Sam Hollingworth

  73. Continuous intrafetal infusion of prostaglandin E2 prematurely activates the hypothalamo-pituitary-adrenal axis and induces parturition in sheep

    Article • Endocrinology, June 1996, Endocrine Society

    Dr Sam Hollingworth

  74. Continuous intrafetal infusion of prostaglandin E2 prematurely activates the hypothalamo-pituitary-adrenal axis and induces parturition in sheep.

    Article • Endocrinology, June 1996, Endocrine Society

    Dr Sam Hollingworth

  75. Rebound increase in fetal breathing movements after 24-h prostaglandin E2 infusion in fetal sheep

    Article • Journal of Applied Physiology, January 1996, American Physiological Society

    Dr Sam Hollingworth

  76. Prostaglandin E2 administered to fetal sheep increases the plasma concentration of adrenocorticotropin (ACTH) and the proportion of ACTH in low molecular weight forms.

    Article • Endocrinology, March 1995, Endocrine Society

    Dr Sam Hollingworth

  77. Prostaglandin E2 administered to fetal sheep increases the plasma concentration of adrenocorticotropin (ACTH) and the proportion of ACTH in low molecular weight forms

    Article • Endocrinology, March 1995, Endocrine Society

    Dr Sam Hollingworth

  78. Chronic administration of low doses of adrenocorticotropin to hypophysectomized fetal sheep leads to normal term labor

    Article • Endocrinology, March 1994, Endocrine Society

    Dr Sam Hollingworth

  79. Effect of Late Hypothalamo-Pituitary Disconnection on the Development of the HPA Axis in the Ovine Fetus and the Initiation of Parturition

    Article • Journal of Neuroendocrinology, February 1994, Wiley

    Dr Sam Hollingworth

  80. The metabolism and excretion of oestradiol-3β-d-glucuronide in rats

    Article • Comparative Biochemistry and Physiology Part B Comparative Biochemistry, January 1988, Elsevier

    Dr Sam Hollingworth